ArrowMark Colorado Holdings’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
ArrowMark Colorado Holdings's HALO Position: Q2 2026 in Review
ArrowMark Colorado Holdings reduced its Halozyme (HALO) stake by 83% in Q2 2026, selling an estimated $32.2M and leaving 97,230 shares worth $7.61M. The position accounts for 0.32% of the portfolio, ranked #130.
ArrowMark Colorado Holdings first reported a position in HALO in Q3 2013 and has held it in 18 quarters since. The position peaked at $115M in Q3 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- ArrowMark Colorado Holdings held 97,230 shares of Halozyme worth $7.61M as of Q2 2026.
- ArrowMark Colorado Holdings sold 472,559 Halozyme shares in Q2 2026, an estimated $32.2M.
- Halozyme made up 0.32% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #130 holding.
- ArrowMark Colorado Holdings first reported a position in Halozyme in Q3 2013 and has held it in 18 quarters since.
- ArrowMark Colorado Holdings's Halozyme position peaked at $115M in Q3 2024.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.